Recruiting
Phase 2

Riluzole

Sponsor:

UCLA

Code:

NCT06580002

Conditions

Breast Cancer

Sarcoma

Gastric Cancer

Lung Cancer

Head and Neck Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Riluzole

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-12. This information was provided to ClinicalTrials.gov by University of California, Irvine on 2025-06-26.